Truncated Recombinant Dobrava Hantavirus Nucleocapsid Proteins Induce Strong, Long-Lasting Immune Responses in Mice

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Intervirology

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000093454PMID 16714853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hantaviruses: Immunology, Treatment, and Prevention

  2004cited by this paper
• Yeast-Expressed Hantavirus Dobrava Nucleocapsid Protein Induces a Strong, Long-Lasting, and Highly Cross-Reactive Immune Response in Mice

  2004cited by this paper
• Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge.

  2004cited by this paper
• Detection of Puumala Hantavirus Antibody with ELISA Using a Recombinant Truncated Nucleocapsid Protein Expressed in Escherichia coli

  2004cited by this paper
• First Molecular Identification of Human Dobrava Virus Infection in Central Europe

  2004cited by this paper
• Hantavirus infections in Europe.

  2003cited by this paper
• Genetic Interaction between Distinct Dobrava Hantavirus Subtypes in Apodemus agrarius and A. flavicollis in Nature

  2003cited by this paper
• Review of an Inactivated Vaccine against Hantaviruses

  2003cited by this paper
• Generation of a Recombinant Cytomegalovirus for Expression of a Hantavirus Glycoprotein

  2003cited by this paper
• Hantavirus infections in Europe.

  2003cited by this paper
• Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells.

  2003cited by this paper
• Hantavirus pulmonary syndrome: the new American hemorrhagic fever.

  2002cited by this paper
• Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model.

  2002cited by this paper
• Cross-Protection against Challenge with Puumala Virus after Immunization with Nucleocapsid Proteins from Different Hantaviruses

  2002cited by this paper
• Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies.

  2002cited by this paper
• Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells

  2001cited by this paper
• DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection.

  2000cited by this paper
• Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles.

  2000cited by this paper
• Cutting Edge: Outer Membrane Protein A (OmpA) Binds to and Activates Human Macrophages

  2000cited by this paper
• Recombinant protein production driven by the tryptophan promoter is tightly controlled in ICONE 200, a new genetically engineered E. coli mutant.

  2000cited by this paper
• Carrier Properties of a Protein Derived from Outer Membrane Protein A of Klebsiella pneumoniae

  1999cited by this paper
• Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice.

  1999cited by this paper
• Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.

  1999cited by this paper
• Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica.

  1998cited by this paper
• Chromosomal sequencing using a PCR-based biotin-capture method allowed isolation of the complete gene for the outer membrane protein A of Klebsiella pneumoniae.

  1998cited by this paper
• The recombinant Klebsiella pneumoniae outer membrane protein OmpA has carrier properties for conjugated antigenic peptides.

  1998cited by this paper
• The hantaviruses of Europe: from the bedside to the bench.

  1997cited by this paper
• Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.

  1997cited by this paper
• A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus.

  1996cited by this paper
• A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus

  1995cited by this paper
• Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae.

  1995cited by this paper
• Haemorrhagic fever with renal syndrome and other hantavirus infections

  1994cited by this paper
• Characterization of Dobrava virus: A hantavirus from Slovenia, Yugoslavia

  1992cited by this paper
• Specific Puumala IgG virus half a century after haemorrhagic fever with renal syndrome.

  1991cited by this paper
• Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay

  1988cited by this paper
• Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome.

  1985cited by this paper

• Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology

  2025cites this paper
• Achievement and Challenges in Orthohantavirus Vaccines

  2025cites this paper
• Hantavirus: an overview and advancements in therapeutic approaches for infection

  2023cites this paper
• Immune response during hantavirus diseases: implications for immunotherapies and vaccine design

  2021cites this paper
• The Immune Correlates of Orthohantavirus Vaccine

  2021cites this paper
• Hantavirus diseases pathophysiology, their diagnostic strategies and therapeutic approaches: A review

  2019cites this paper
• Progress on the Prevention and Treatment of Hantavirus Disease

  2019cites this paper
• Характеристика хантавирусов - возбудителей зоонозных геморрагических лихорадок

  2017cites this paper
• Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses

  2015cites this paper
• Novel Technologies for Vaccine Development

  2014cites this paper
• Current Status of Hantavirus Vaccines Development

  2014cites this paper
• Evaluation of a Recombinant Rift Valley Fever Virus Subunit Nucleocapsid Protein as an Immunogen in Mice and Sheep

  2010cites this paper
• MONTAGEM DE UM PSEUDO-HANTAVÍRUS QUIMERA, CONTENDO A NUCLEOPROTEÍNA DO VÍRUS ARARAQUARA E AS GLICOPROTEÍNAS DO VÍRUS ANDES, EM SISTEMA BACULOVÍRUS

  2010cites this paper
• NMR STUDIES OF BACTERIAL TYPE III SECRETION APPARATUS NEEDLE AND TIP PROTEINS AND THE NMR STRUCTURE OF THE HANTAVIRUS NUCLEOCAPSID COILED-COIL DOMAIN

  2009cites this paper
• Recent approaches in hantavirus vaccine development

  2009cites this paper
• Technical transformation of biodefense vaccines.

  2009cites this paper
• Truncated Recombinant Puumala Virus Nucleocapsid Proteins Protect Mice Against Challenge in Vivo

  2008cites this paper
• NMR Structure of the N-terminal Coiled Coil Domain of the Andes Hantavirus Nucleocapsid Protein*

  2008cites this paper
• Emerging Zoonoses: Hantavirus-Infektionen

  2007cites this paper
• HSP70 gene fused with Hantavirus S segment DNA significantly enhances the DNA vaccine potency against hantaviral nucleocapsid protein in vivo.

  2007cites this paper